Suicide gene therapy kills prostate tumor cells

The image on the left shows high-grade aggressive prostate cancer before treatment. the image on the right shows no evidence of cancer after combined gene therapy and radiotherapy.

Credit: Houston Methodist

Results from a long-term clinical trial conducted by researchers at Methodist Hospital Houston show that combining radiation treatment with "suicide gene therapy," a technique in which prostate cancer cells are genetically modified so they signal a patient's immune system to attack them, provides a safe and effective one-two punch against the disease.

The researchers compared 2 arms of patients and report high five-year overall survival rates of ninety seven p.c and ninety four p.c, severally. that is a 5 to twenty p.c improvement for survival over historical studies. These findings ar within the Dec. twelve on-line issue of the Journal of Radiation medical specialty (JRO).

Sixty-six glandular carcinoma patients participated within the {phase ii|phase II test|phase II|clinical trial|clinical test} clinical trial between 1999 and 2003 and were split into 2 teams. One cluster with cancer cells confined to the prostate, selected Arm A, received solely therapy whereas the opposite with a additional aggressive glandular carcinoma, Arm B, received each radiation and secretion therapies. Patients in Arm A received the experimental factor medical care doubly throughout the study, whereas the Arm B cluster received the treatment 3 times.

"We strategically used associate animal virus, kind of like the one that causes the respiratory disorder, to hold the medical care agent--a herpes factor that produces the accelerator deoxythymidine enzyme, or TK--directly into the growth cells," said E. Brian pantryman, M.D., chair of the Department of Radiation medical specialty at Houston Methodist and senior author on the JRO paper. "Once the herpes factor was delivered and it started producing TK, we have a tendency to gave patients a usually used anti-herpes drug, valacyclovir. the mix attacked the herpes polymer, and therefore the TK-producing growth cells self-destructed, that is why the procedure is termed 'suicide factor medical care.'"

Butler aforementioned that after the activated valacyclovir (trade name: Valtrex) starts destroying growth cells, it additionally alerts the patient's system, antecedently unaware of the cancer's presence, that it's time to launch a colossal attack.

"We have created a vaccinum with the patient's own cancer cells, a treatment that enhances, and will even enhance, what we will attain with ancient radiation and secretion therapies," aforementioned pantryman, academic of radiation medical specialty, composer Cornell medication.

According to the results reportable within the JRO paper, the long outcome for glandular carcinoma patients receiving factor medical care together with {radiotherapy|radiation medical care|radiation|actinotherapy|irradiation|therapy} with or while not secretion therapy is promising. The sixty two patients in each arms UN agency completed the test had remarkably high five-year freedom from failure rates, that means no indication by organic chemistry testing of cancer repeat, of ninety four p.c and ninety one p.c, severally. Prostate biopsies performed at twenty four months when completion of treatment were negative in eighty three p.c of Arm A patients and seventy nine p.c of Arm B patients.

For all appraising factors, the outcomes were remarkably more than those achieved with therapy alone (in knowledge taken from historical studies used as controls).

"This is very pleasing to America, considering we have a tendency to had patients registered in our protocol when different physicians deemed them incurable," aforementioned Bin Teh, M.D., vice chair of Houston Methodist's Department of Radiation medical specialty and lead author on the JRO paper. "We firmly believe this may be a viable treatment strategy."

Adding to the spectacular therapeutic results, Teh said, is that the undeniable fact that the bulk of patients within the test toughened very little or no aspect effects or complications. A clinical test patient trial, the ultimate safety and efficaciousness analysis for the unaltered  immunomodulatory factor medical care before it are often approved by the Food and Drug Administration, is already afoot. glandular carcinoma is that the most typical cancer in men and causes important mortality.

---

Story Source:

The above post is reprinted from materials provided by Houston Methodist.Note: Materials may be edited for content and length.

Read More

Novel stem cell line avoids risk of introducing transplanted tumors

In this micrograph, embryonic rat kidney cell aggregates are colored red. Differentiated human cells incorporated into these aggregates are colored green. Blue marks DNA in all cells.

Credit: UC San Diego Health

Human pluripotent stem cells (hPSC) can become any type of cell in the adult body, offering great potential in disease modeling, drug discovery and creating replacement cells for conditions ranging from cardiovascular to Alzheimer's disease.

But that promise comes with a risk: the possibility that transplanted hPSCs might also develop as unwanted tumors. In a new study published November 10, 2015 in the online journal eLIFE, researchers at University of California, San Diego School of Medicine describe a new "progenitor cell" capable of unlimited expansion and differentiation into mature kidney cells, but without the risk of forming tumors.

"This work nicely complements recent advances in tissue engineering and the goal of rebuilding or recreating functional organs, such as what we've seen with the creation of 'mini-kidneys'," said senior author Karl Willert, PhD, associate professor in the Department of Cellular and Molecular Medicine at UC San Diego. "It represents a novel source of cells."

Willert, with co-corresponding author David Brafman, PhD, at Arizona State University, and colleagues engineered an in vitro microenvironment that permitted homogenous expansion of hPSC progenitor cells from the mesoderm -- one of the three primary germ layers in early embryonic development. A germ layer is a primary layer of cells that form during embryogenesis. Progenitor cells are early descendants of stem cells, with more limited differentiation capacity.

Analyses showed that these newly created "mesoderm progenitors" lacked tumor-forming potential, but retained the capacity to differentiate into specific kinds of tissue, such as cells that comprise the adult kidney.

The researchers said the ability to generate expandable populations of progenitor cells with limited differentiation presents several advantages over the use of undifferentiated human stem cells:

First, cultures derived from the latter often harbor undifferentiated cells that retain the potential to seed tumor growth.

Second, development and manipulation of lineage-restricted progenitors is less elaborate. It's easier to create mature cell populations for research or therapeutic use.

Third, because progenitor cells are limited in what kind of cell they can be, they are less likely than stem cells to differentiate into an unwanted cell type.

"Our cells can serve as building blocks to generate kidneys that may one day be suitable for cell replacement and transplantation," said Willert. "I think such a therapeutic application is still a few years in the future, but engineered kidney tissue can serve as a powerful model system to study how the human kidney interacts with and filters drugs. Such an application would be of tremendous value to the pharmaceutical industry."

Willert noted that the progenitor cells developed are likely capable of differentiating into other cell types of the intermediate mesodermal lineage as well, most notably the germ line to generate eggs and sperm in a dish. "We have only characterized their potential to differentiate into cells that contribute to the kidney. We are now investigating to what extent these cells can generate other tissues and organs that derive from intermediate mesoderm, including reproductive organs."

He said colleagues are also pursuing similar bioengineering-based approaches to generate other similar expandable progenitor cell populations capable of differentiation into mature cell types derived from other germ layers.

---

Story Source:

The above post is reprinted from materials provided by University of California, San Diego Health Sciences. Note: Materials may be edited for content and length.

Read More